sertraline ODT is one of 83 small molecule programs targeting Panic Disorder. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2828 competitors in Breast Cancer
MS Contin
Zolymbus
Effexor
Spravato
Zoladex
Motexafin Gadolinium
Metfomin
Perflutren Lipid Microsphere
Conventional Chemotherapy
Bisphosphonate
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details